NRx Pharmaceuticals Inc. (NRXP)
NASDAQ: NRXP
· Real-Time Price · USD
2.75
0.12 (4.56%)
At close: Sep 05, 2025, 3:59 PM
2.64
-4.00%
After-hours: Sep 05, 2025, 07:43 PM EDT
4.56% (1D)
| Bid | 2.72 |
| Market Cap | 54.07M |
| Revenue (ttm) | 4K |
| Net Income (ttm) | -33.79M |
| EPS (ttm) | -2.21 |
| PE Ratio (ttm) | -1.24 |
| Forward PE | 1.11 |
| Analyst | Buy |
| Ask | 2.8 |
| Volume | 172,909 |
| Avg. Volume (20D) | 314,616 |
| Open | 2.65 |
| Previous Close | 2.63 |
| Day's Range | 2.57 - 2.75 |
| 52-Week Range | 1.10 - 6.01 |
| Beta | 1.64 |
About NRXP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRXP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NRXP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
NRx Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 13, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-1.9%
NRXP stock has given up its prior gain. NRX Pharma...
Unlock content with
Pro Subscription
1 week ago
-1.9%
NRX Pharmaceuticals shares are trading higher after the company announced the FDA has granted fast-track designation for NRX-100.
2 weeks ago · seekingalpha.com
NRx Pharmaceuticals, Inc. (NRXP) Q2 2025 Earnings Call TranscriptNRx Pharmaceuticals, Inc. (NASDAQ:NRXP ) Q2 2025 Earnings Conference Call August 20, 2025 8:00 AM ET Company Participants Jonathan C. Javitt - Co-Founder, Chief Scientist Officer, Chairman & Interim C...
2 months ago · https://www.defenseworld.net
Squarepoint Ops LLC Makes New Investment in NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)Squarepoint Ops LLC purchased a new position in NRx Pharmaceuticals, Inc. (NASDAQ:NRXP – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchang...